Det betyder, at Retacrit svarer til et biologisk lægemiddel, der allerede er godkendt i EU og indeholder et lignende aktivt stof (dette kaldes referencelægemidlet).
This means that Retacrit is similar to a biological medicine that is already authorised in the European Union (EU) and contains a similar active substance (also known as the ‘ reference medicine’).